Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov official registry

Healthy, no Evidence of Disease clinical trials

Every US clinical trial registered for Healthy, no Evidence of Disease — phase mix, recruiting status, and the sponsors running them, straight from the NIH ClinicalTrials.gov registry.

11 US clinical trials ·

The research picture

Healthy, no Evidence of Disease has 11 registered US clinical trials; none are currently listed as recruiting, so most are completed or in follow-up.

0
recruiting participants now
0%
of trials open to enrollment
0
in Phase 3–4 (later-stage)
5
top sponsor: National Cancer Institute (NCI)

Counts reflect the public ClinicalTrials.gov registry as last mirrored by PlainTrial. Status and phase are reported by each study's sponsor. This is reference information, not medical advice.

Active & Recent Trials

COMPLETED 780 participants

Study of a Smart Growth Community's Effect on Prevention of Obesity in Middle-, Moderately Low- and Low-Income Families

University of Southern California

NCT00986011

COMPLETED NA 697 participants

Genetic Epidemiology Risk Assessment Program or Usual Care in Colorectal Cancer Screening for Healthy Participants

Fox Chase Cancer Center

NCT00478309

COMPLETED NA 183 participants

Exercise Programs in Healthy Young Women at Increased Risk of Developing Breast Cancer

Abramson Cancer Center at Penn Medicine

NCT00892515

COMPLETED Phase 1 112 participants

Letrozole in Preventing Breast Cancer in Healthy Postmenopausal Women at High Risk for Breast Cancer

National Cancer Institute (NCI)

NCT01077453

COMPLETED 37 participants

Molecular Markers in Predicting Lung Cancer Development Using Tissue Samples From Healthy Participants

Vanderbilt-Ingram Cancer Center

NCT00899457

COMPLETED Phase 1 36 participants

Se-Methyl-Seleno-L- Cysteine (MSC) in Treating Healthy Patients

National Cancer Institute (NCI)

NCT00489372

COMPLETED Phase 1 24 participants

Linaclotide Acetate in Preventing Colorectal Cancer in Healthy Volunteers

Mayo Clinic

NCT01950403

COMPLETED Phase 1 20 participants

Studying Different Formulations of SR13668 in Healthy Volunteers

National Cancer Institute (NCI)

NCT00896207

COMPLETED Phase 1 20 participants

Lycopene in Healthy Male Participants

National Cancer Institute (NCI)

NCT00450957

COMPLETED Phase 1 14 participants

Diindolylmethane in Healthy Volunteers

National Cancer Institute (NCI)

NCT00392652

COMPLETED NA 11 participants

A Nutritional Supplement Capsule Containing Curcumin, Green Tea Extract, Polygonum Cuspidatum Extract, and Soybean Extract in Healthy Participants

Barbara Ann Karmanos Cancer Institute

NCT00768118

Phase Distribution

PhaseTrial count
Phase 1 6

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Reading the Healthy, no Evidence of Disease Trial Landscape

ClinicalTrials.gov lists 11 US studies indexed under Healthy, no Evidence of Disease, and 0 of those are currently open to recruitment — roughly 0% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.

The phase distribution for Healthy, no Evidence of Disease shows 0 late-stage studies (Phase 3 and Phase 4 combined) alongside 6 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.

Top sponsor activity for Healthy, no Evidence of Disease is led by National Cancer Institute (NCI) with 5 indexed trials, alongside 6 other organizations in the top contributor list. The list on this page surfaces up to 11 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.

Frequently Asked Questions

How many clinical trials are there for Healthy, no Evidence of Disease?

PlainTrial tracks 11 US clinical trials for Healthy, no Evidence of Disease, of which 0 are currently recruiting participants. Data sourced from ClinicalTrials.gov.

How do I find a recruiting trial for Healthy, no Evidence of Disease?

Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.

Is this data current?

Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.

Related

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.

Verify with NIH →